At Peet & Associates, we empower biotech and pharmaceutical companies to navigate the intricate landscape of intellectual property with confidence and strategic insight.
Led by Dr. Richard Peet who has 30 years of expertise in both molecular biology and patent law, our firm specializes in serving the diverse needs of life sciences companies competing in a global marketplace.
Dr. Peet has real world experience in the field of life sciences. He founded Formulate Biosciences, Inc., a leader in the sustainable and eco-friendly production of natural products using enzyme technology. He is also an inventor on numerous granted patents that protect valuable innovations in the areas of biocatalysis and natural products including prebiotics.
At Peet & Associates, we don’t just protect innovations; we enable pioneering companies to thrive on a global scale.
We offer comprehensive services including:
A representative sample of some of Dr. Peet’s important legal cases in which he made significant contributions including:
J.R. Simplot
Worked closely with the J.R. Simplot Company management to launch and build the intellectual property portfolio for the company’s very successful biotechnology business.
Frenzy Crop Systems, Inc.
Dr. Peet helped to establish Frenzy Crop Systems, Inc. and build the company’s patent portfolio covering methods and chemical formulations for improving plant agronomic traits.
Keygene N.V.
Dr. Peet assisted Keygene N.V. in securing U.S. patents with claims directed to use of next-generation DNA sequencing to identify genetic variations in plants. Based on these patents, Keygene sued Floragenex for patent infringement resulting in a negotiated settlement in which Floragenex agreed to pay Keygene royalties for use of the patented technologies.